Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Amazon Restructures Healthcare Business to Drive Growth and Simplify Operations

by Team Lumida
June 17, 2025
in Markets
Reading Time: 4 mins read
A A
0
Amazon’s $100 Billion Bet: AI Over Retail

Source: RMC

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Amazon Health Services (AHS) has been reorganized into six new divisions, each led by longtime Amazon executives or leaders from its$3.9 billion One Medical acquisition.
  • The restructuring aims to simplify AHS’ structure, accelerate innovation, and expand its healthcare offerings, including telehealth, chronic care management, and pharmacy services.
  • Despite past setbacks, such as the closure of Amazon Care and Haven, Amazon has seen momentum in healthcare, with strong uptake in pharmacy services and plans to expand One Medical offices.
  • The restructuring follows the departure of several high-level executives, including One Medical CEO Trent Green and Amazon Pharmacy’s Chief Medical Officer Dr. Vin Gupta.

What Happened?

Amazon has restructured its healthcare business, Amazon Health Services (AHS), into six new divisions to streamline operations and drive growth. The reorganization, completed in May, comes after mixed results in the healthcare sector and the departure of key executives.

The six divisions are led by a mix of longtime Amazon executives and leaders from One Medical, which Amazon acquired in 2023 for$3.9 billion. The restructuring reflects Amazon’s broader strategy to deliver better patient care and accelerate innovation across its healthcare offerings.

Amazon’s healthcare initiatives include telehealth, chronic condition management, pharmacy services, and a national physician network through One Medical. While some ventures, like Amazon Care and Haven, failed to gain traction, the company has recently reported strong momentum in pharmacy services and is expanding One Medical offices in states like New York, New Jersey, and Ohio.


Why It Matters?

Amazon’s restructuring highlights its commitment to becoming a major player in the healthcare industry, despite past challenges. The company’s focus on consumer-centric services, such as same-day medication delivery and caregiver-controlled drug orders, positions it to compete with traditional healthcare providers and other tech-driven entrants.

The reorganization also underscores the importance of leadership in driving innovation and growth. By appointing experienced Amazon executives and One Medical leaders to helm its new divisions, Amazon aims to leverage its expertise in logistics, technology, and customer experience to disrupt the healthcare sector.

However, the departure of high-level executives raises questions about the company’s ability to retain top talent and navigate the complexities of the healthcare industry.


What’s Next?

Amazon plans to continue expanding its healthcare footprint, with a focus on growing One Medical’s presence and enhancing its pharmacy offerings. The company’s ability to execute its restructured strategy will be critical to its success in the highly competitive and regulated healthcare market.

Investors and industry stakeholders will closely monitor Amazon’s progress, particularly in areas like telehealth, chronic care management, and partnerships with health systems. The company’s ability to innovate and scale its healthcare services will determine whether it can overcome past setbacks and establish itself as a leader in the sector.

Source
Previous Post

At Home Files for Chapter 11 Bankruptcy Amid Tariff Pressures and Mounting Debt

Next Post

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Recommended For You

Short Seller Andrew Left Convicted of Fraud — and Wall Street Is Rattled

by Team Lumida
2 days ago
stock market candlestick chart on dark screen

Citron Research founder Andrew Left was convicted of securities fraud for trading against his own publicly stated positions, sending a chill through short sellers and anyone who publicly...

Read more

Broadcom’s AI Revenue Miss Triggers Tech Selloff; SpaceX Confirms $75 Billion IPO

by Team Lumida
2 days ago
SpaceX Makes the Rockets — But Starlink Is What’s Actually Paying for Mars

Broadcom fell 14% after its AI chip revenue forecast missed — wiping back much of this week's $150B gain — while SpaceX confirmed a June 11 IPO targeting...

Read more

Greg Abel Makes His Mark: Berkshire’s New CEO Closes $16.8 Billion in Deals in One Weekend

by Team Lumida
3 days ago
Greg Abel Makes His Mark: Berkshire’s New CEO Closes $16.8 Billion in Deals in One Weekend

Warren Buffett's successor acquired homebuilder Taylor Morrison for $6.8 billion and bought $10 billion in Alphabet shares in a single weekend, silencing doubters and putting Berkshire's $380 billion...

Read more

Huawei’s ‘Tau Law’ Breakthrough Is Actually a Confession That Export Controls Are Working

by Team Lumida
4 days ago
Huawei’s ‘Tau Law’ Breakthrough Is Actually a Confession That Export Controls Are Working

WSJ China: Huawei unveiled a chip-stacking technique it calls the Tau Law as Moore's Law successor — but independent analysts say the paper inadvertently admits Huawei can't crack...

Read more

Why ‘Nvidia Inside’ Can Work — and Why It Threatens Intel’s Last Stronghold

by Team Lumida
4 days ago
Nvidia CEO Reveals Secrets Behind AI Domination Amidst Fierce Competition

WSJ Heard on the Street: Nvidia's RTX Spark PC chip combines a CPU with its AI silicon in a direct assault on Intel and AMD's x86 dominance. With...

Read more

SpaceX Is Squeezing Banks to Under 0.75% on Its $75B IPO — They’ll Still Pocket ~$500 Million

by Team Lumida
4 days ago
SpaceX Makes the Rockets — But Starlink Is What’s Actually Paying for Mars

SpaceX is negotiating razor-thin banker fees below 0.75% on its record $75 billion IPO — but at that scale the absolute dollar payout to Goldman, Morgan Stanley, and...

Read more

Citadel to Pay Other Hedge Funds for Their Best Trade Ideas in New Alpha-Capture Program

by Team Lumida
4 days ago
Citadel to Pay Other Hedge Funds for Their Best Trade Ideas in New Alpha-Capture Program

Ken Griffin's Citadel is launching a buyside alpha-capture program — paying external discretionary managers for trading signals to feed into its quantitative strategies. It's the latest move by...

Read more

Walmart-Backed OnePay Is Quietly Building a Super App to Rival America’s Banks

by Team Lumida
4 days ago
a walmart store with a car parked in front of it

OnePay — backed by Walmart and Ribbit Capital's Micky Malka — has doubled to 6 million monthly active users and $50B in annualized payments in a year, with...

Read more

Bond Traders Are Betting on a Fed Rate Hike — and Friday’s Jobs Report Is the Test

by Team Lumida
5 days ago
stock market candlestick chart on dark screen

With PCE inflation running at 3.8% and oil elevated by Iran war risk, bond traders are pricing in a Fed hike by mid-2027. Friday’s May payrolls report —...

Read more

SpaceX’s IPO Is So Big It’s Forcing Wall Street to Rewrite Its Own Rules

by Team Lumida
5 days ago
SpaceX’s IPO Is So Big It’s Forcing Wall Street to Rewrite Its Own Rules

Bloomberg’s Big Take: SpaceX’s $75B raise at a $1.8T valuation is forcing index providers to fast-track inclusion rules, passive funds to model $20B in forced buying, and retail...

Read more
Next Post
white and blue airplane on airport during daytime

Airbus to Boost Shareholder Returns Amid Strong Aircraft Demand

Why Berkshire’s Latest Yen Bond Sale Could Ignite the Japanese Market

Japan’s Exports Decline for First Time in Eight Months Amid U.S. Tariff Pressures

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

black and white star logo

Ether Leads Crypto Selloff Amid Trump’s Tariff Escalation on Chinese Goods

April 9, 2025
Snowflake Acquires Crunchy Data for $250 Million to Boost AI Agent Development

Snowflake Acquires Crunchy Data for $250 Million to Boost AI Agent Development

June 3, 2025
Nvidia CEO Jensen Huang Sells $169M in Shares Amid AI Boom

Nvidia Gains on Strong AI Demand Signals from Key Supplier Foxconn

March 14, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018